The Clinical Evidence of a Blood Test to Rule out EAC
Explore the Published Clinical Evidence Behind Promarker®Eso
The Promarker®Eso Clinical Compendium is a detailed resource designed for healthcare professionals seeking to understand how protein-based precision diagnostics are reshaping the management of esophageal cancer risk for people living with chronic reflux (GORD/GERD). With the rapidly rising global incidence of Esophageal Adenocarcinoma, early risk detection is more critical than ever.
Promarker®Eso offers a unique, evidence-based solution — identifying your GORD/GERD patient's risk of EAC.